Welcome to the generation that inherited anxiety, debt, and a dying planet. In this new video, we dig into why Gen Z is now ...

They say the Blue Hole is cursed. That it calls divers down, never to return. Yuri didn’t believe in legends until he became ...

Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating ...

HEAL seeks to provide investors exposure to the growing HealthTech industry, which is expected to grow fourfold from $225 billion in 2022 to over $1 trillion by 2032.

Genius Sports Limited ( NYSE:GENI ) is possibly approaching a major achievement in its business, so we would like ...

The summary describes the design of Johnson & Johnson's Phase 3 AZALEA trial, which will evaluate the efficacy of nipocalimab in HDFN.

The last weeks of 2024 have brought monumental changes to the Syrian situation, triggered by events in Gaza and Lebanon. On December 8, 2024, Syrian President ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

In this In Focus, we explore how organ-on-a-chip technology is being used to improve drug discovery and development.

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, and accelerating timelines.